Stockscreener 앱 받기
24.09
2.39%
-0.59
시간 외 거래:
24.09
전일 마감가:
$24.68
열려 있는:
$25.05
하루 거래량:
188.51K
Relative Volume:
1.49
시가총액:
$408.26M
수익:
$978.76M
순이익/손실:
$-286.52M
주가수익비율:
-1.3908
EPS:
-17.3212
순현금흐름:
$-31.63M
1주 성능:
+11.32%
1개월 성능:
-37.31%
6개월 성능:
+41.21%
1년 성능:
-52.76%
1일 변동 폭
$23.01
$25.05
1주일 범위
$20.24
$25.05
52주 변동 폭
$11.50
$73.68
Claritev Corp Stock (CTEV) Company Profile
명칭
Claritev Corp
전화
212-780-2000
주소
7900 TYSONS ONE PLACE, MCLEAN
Compare CTEV vs VEEV, TEM, BTSG, TXG, HNGE
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CTEV
Claritev Corp
|
24.09 | 393.18M | 978.76M | -286.52M | -31.63M | -17.32 |
VEEV
Veeva Systems Inc
|
283.50 | 45.44B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
71.98 | 15.43B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
63.75 | 11.20B | 13.65B | 169.86M | 412.12M | 1.0758 |
TXG
10 X Genomics Inc
|
80.66 | 11.17B | 638.78M | -22.66M | 122.18M | -0.1744 |
HNGE
Hinge Health Inc
|
98.35 | 7.71B | 646.34M | -512.40M | 202.76M | -6.6871 |
Claritev Corp Stock (CTEV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-24 | 개시 | Barclays | Overweight |
| 2026-01-12 | 개시 | Guggenheim | Buy |
| 2026-01-09 | 개시 | Wells Fargo | Equal Weight |
| 2025-10-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-05-29 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-06-26 | 개시 | Piper Sandler | Neutral |
| 2022-12-13 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-07-12 | 개시 | Goldman | Neutral |
| 2021-10-04 | 재개 | Citigroup | Buy |
| 2021-04-07 | 개시 | B. Riley Securities | Buy |
| 2021-03-19 | 개시 | Barclays | Equal Weight |
모두보기
Claritev Corp 주식(CTEV)의 최신 뉴스
Claritev Corp (CTEV) Shares Fall 3.7% -- What GF Score of 61 Tel - GuruFocus
Calif. Appeals Court Revives Antitrust Suit Against Claritev - Law360
Claritev Corporation (CTEV) Stock Price, News, Quote & History - ca.finance.yahoo.com
Claritev Corporation (CTEV) stock price, news, quote and history - Yahoo Finance Singapore
Douglas Michael Garis Sells 9,025 Shares of Claritev (NYSE:CTEV) Stock - MarketBeat
Claritev : Five Shifts Reshaping TPA Cost Management - marketscreener.com
Claritev (CTEV) CFO sells stock under pre-set plan - Stock Titan
CTEV Looks 10.5% Overvalued on GF Value™ - GuruFocus
Claritev Corporation Is Selected By General Dynamics Information Technology To Support CDC?s World Trade Center Health Program - marketscreener.com
Claritev Selected by GDIT to Support CDC’s World Trade Center Health Program - Yahoo Finance
Planned Claritev (NYSE: CTEV) stock sale tops $278K - Stock Titan
Claritev (NYSE:CTEV) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Claritev Corp (CTEV) Stock Down 5.5% but Still Overvalued -- GF Score: 63/100 - GuruFocus
Claritev (NYSE:CTEV) Shares Down 4.3%Should You Sell? - MarketBeat
Claritev Releases 2025 Corporate Responsibility Report - Yahoo Finance
New Claritev (CTEV) director gets 2,880-share RSU award - Stock Titan
Claritev (NYSE: CTEV) Appoints Ben Letham as Director to Strengthen Board with AI Expertise - Kalkine Media
Claritev at Morgan Stanley healthcare conference: turnaround gains pace - Investing.com
Claritev at Morgan Stanley healthcare conference: turnaround gains pace By Investing.com - Investing.com UK
Form 8K Claritev Corp For: 15 September By Investing.com - Investing.com Australia
Claritev appoints Meta AI researcher Ben Letham to board - Investing.com
Claritev appoints Meta AI researcher Ben Letham to board By Investing.com - Investing.com UK
A Meta AI researcher joins Claritev’s board - Stock Titan
Claritev (NYSE:CTEV) Trading Up 4%Time to Buy? - MarketBeat
Claritev Cares Helps Rural Patients Get Critical Care Closer to Home - Stock Titan
Claritev’s (CTEV) Profit Picture Brightens, But Its Cash Cushion Shrinks - Yahoo Finance
Bank of America Corp DE Purchases 58,133 Shares of Claritev $CTEV - MarketBeat
Claritev (NYSE:CTEV) CEO Buys 4,500 Shares of Stock - MarketBeat
Claritev CEO Travis Dalton buys $249,663 in company stock By Investing.com - Investing.com South Africa
Claritev CEO Travis Dalton buys $249,663 in company stock - Investing.com
Travis Dalton Purchases 1,950 Shares of Claritev (NYSE:CTEV) Stock - MarketBeat
Claritev (CTEV) CEO adds 6,450 shares via spouse IRA - Stock Titan
Claritev Corporation Announces Participation in Upcoming Events - Yahoo Finance
Is Claritev Corp (CTEV) Overvalued After 9.4% Rally? GF Value Sa - GuruFocus
CTEV Maintained by Barclays -- Price Target Raised to $40.00 - GuruFocus
Claritev (CTEV) Q2 2026 Earnings Call Transcript - AOL.com
Claritev (NYSE:CTEV) SVP Tiffani Misencik Sells 8,850 Shares - MarketBeat
Claritev Corp (CTEV) exec sells 8,850 shares, holds 123,723 - Stock Titan
Claritev (NYSE:CTEV) Shares Gap DownHere's Why - MarketBeat
Claritev Chief Growth Officer Tiffani Misencik sells 8,850 shares worth $354,592.95 - Bitget
Claritev says Marpai expands contract for pre- and post-payment claims integrity services - Bitget
CTEV Looks 33.2% Overvalued on GF Value™ - GuruFocus
Marpai expands Claritev agreement for payment integrity By Investing.com - Investing.com Australia
Marpai expands Claritev agreement for payment integrity - Investing.com
Marpai expands beyond network access—but what comes next? - Stock Titan
Marpai Expands Relationship With Claritev To Help Reduce Healthcare Costs For Employer Clients - TradingView
Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients - Business Wire
Claritev $CTEV Shares Sold by Renaissance Technologies LLC - MarketBeat
Claritev (NYSE:CTEV) Rating Increased to Hold at Zacks Research - MarketBeat
Claritev Corp SEC Filing (Aug 14, 2026) - Stock Titan
Claritev (NYSE:CTEV) Shares Down 5.1%Time to Sell? - MarketBeat
Claritev Corp (CTEV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.07%
2.91%
자본화:
|
볼륨(24시간):